MediciNova and Avigen ink final merger agreement
This article was originally published in Scrip
Executive Summary
MediciNova and Avigen have entered a definitive merger agreement in a deal valued at $37 million. The transaction is expected to close in the fourth quarter, subject to shareholder approval and other standard conditions.